In addition, PRR14 has been reported to be overexpressed in patients with NSCLC, and further results showed that PRR14 may be a new activator of PI3K/Akt signaling pathway in NSCLC development. This evidence concerns the gene PRR14 and non-small cell lung carcinoma.